依诺肝素在血液透析抗凝治疗中的应用优势
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

四川省青年科技创新研究团队


Application advantages of the enoxaparin in the hemodialysis anticoagulation therapy
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    【摘要】目的 探讨依诺肝素在血液透析抗凝治疗中的应用优势, 为合理用药提供依据。方法 选取2016年4月~2017年4月在我院血液净化中心行维持性血液透析治疗的60例患者为研究对象, 随机分为对照组和观察组, 每组各30例。对照组采用低分子肝素钙注射液作为抗凝剂, 观察组采用依诺肝素钠注射液作为抗凝剂。治疗并观察两月。比较两组患者在发生脱发、出血、透析器凝血等并发症方面的区别;比较两组患者治疗前后血小板数目等指标。结果 与对照组相比, 观察组患者在发生凝血、出血及脱发的百分率方面较低, 但差异均无统计学意义(P>005);与对照组总的并发症发生方面相比, 观察组更低, 差异具有统计学意义(P<005);两组患者在治疗前后血小板计数方面均无显著性差异(P>005)。结论 依诺肝素钠注射液对于血液透析患者的抗凝治疗疗效确切, 并发症少, 可在临床推广应用。

    Abstract:

    【Abstract】Objective To explore the application advantages of the enoxaparin in the hemodialysis anticoagulation therapy and provide the rational use of drugs.Methods 60 patients of maintenance hemodialysis were chosen from April 2016 to April 2017 in the blood purification center of our hospital and randomly divided into control group (n=30) and observation group (n=30). The control group was treated with low molecular weight heparin calcium injection as anticoagulant, while the Enoxaparin sodium injection was used as anticoagulant in the observation group. Patients were treated and observed for two weeks. Complications of the hair loss, bleeding and the dialysis coagulation were compared between the two groups. The platelet counts before and after the treatment were compared Results Compared with the control group, there were no significant differences in the percentage of coagulation, hemorrhage and alopecia between observation group and control group (P>005). The total complications of the observation group was lower than that of control group(P<005). There was no significant difference in platelet count between the two groups (P>005).Conclusion Enoxaparin sodium injection was effective to the anticoagulant therapy for hemodialysis patients, which was with fewer complications.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2018-03-05
您是第位访问者
版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司